| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/12/2001 | EP1132396A1 Physiologically active peptides |
| 09/12/2001 | EP1131467A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131443A2 Human hydrolase proteins |
| 09/12/2001 | EP1131429A1 Calcium binding protein |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131425A2 Inflammation-associated genes |
| 09/12/2001 | EP1131357A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 09/12/2001 | EP1131352A2 Rantes-derived peptides with anti-hiv activity |
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131333A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131294A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 09/12/2001 | EP1131290A1 Piperidine ccr-3 receptor antagonists |
| 09/12/2001 | EP1131098A1 Cd25 binding molecules for use in the treatment of manifestations of rejection in transplantation |
| 09/12/2001 | EP1131096A1 Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants |
| 09/12/2001 | EP1131092A1 Intradermal avian immunization with inactivated vaccines |
| 09/12/2001 | EP1131086A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto |
| 09/12/2001 | EP1131084A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 09/12/2001 | EP1131080A2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
| 09/12/2001 | EP1131065A2 Utilisation of dialkylfumarates |
| 09/12/2001 | EP1131039A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 09/12/2001 | EP0839206B1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 09/12/2001 | EP0687300B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
| 09/12/2001 | EP0637249B1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 09/12/2001 | EP0629203B1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/12/2001 | EP0621898B1 Chimeric immunogens |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312807A Inhibitors of glycogen synthase kinase 3 |
| 09/12/2001 | CN1312725A Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312706A Medicinal aerosol for mulations |
| 09/12/2001 | CN1312287A Human zinc finger protein 13 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312283A Human cytochrome constituting protein 14 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312260A Human proteinase regulating protein 10 as one new polypeptide and polynucleotides encoding this polypeptide |
| 09/12/2001 | CN1312254A Novel nucleoside |
| 09/12/2001 | CN1312077A Composite component comprising the effective extracts of licorice and lightyellow sophora and its application |
| 09/12/2001 | CN1070868C Peptides as therapeutic agents for treatment of auto-immune diseases |
| 09/12/2001 | CN1070866C Superagonists and antagonists and superantagonists of H IL-6, and 3-D modelling method for their selection |
| 09/12/2001 | CN1070697C Method of preparing novel microcapsule |
| 09/11/2001 | US6288237 Plant protection. immunosuppression and/or be used to combat malignant tumours; they are particularily preferred as cytostatic agents. |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288098 Administering n-(4-trifluoromethyl)-5-methylisoxazole-4-carboxanilide and n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288069 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 09/11/2001 | US6288062 Interleukin and tumor necrosis factor inhibitors; antiinflammatory agents; rheumatic diseases; antiarthritic agents; respiratory system disorders |
| 09/11/2001 | US6288047 Lipid-based immune modulator composition |
| 09/11/2001 | US6288035 Administering polypeptide as antitumor agent to treat melanoma; medical diagnosis |
| 09/11/2001 | US6288029 Template assembled synthetic peptide effective to treat respiratory system disorders |
| 09/11/2001 | US6287803 Polynucleotides encoding a novel era polypeptide |
| 09/11/2001 | US6287576 Biostimulating agent |
| 09/11/2001 | US6287571 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 09/11/2001 | US6287569 Vaccines with enhanced intracellular processing |
| 09/11/2001 | US6287565 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 09/11/2001 | US6287563 Administering heat labile entertoxin |
| 09/11/2001 | US6287559 Cloning and recombinant production of vespid venom hyaluronidases, and immunological therapies based thereon |
| 09/11/2001 | US6287557 Methods of gene therapy using herpes viral vectors expressing GM-CSF |
| 09/11/2001 | US6287556 Intracellular delivery vehicles |
| 09/11/2001 | CA2230936C 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/07/2001 | WO2001065259A1 Method of examining allergic diseases |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064901A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis |
| 09/07/2001 | WO2001064896A2 Human enzyme molecules |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064754A1 Gene recombinant antibody and its fragment |
| 09/07/2001 | WO2001064733A1 A new polypeptide- human reverse transcription-related factor22 and the polynucleotide encoding it |
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064685A2 Thienopyridine derivatives and their use as anti-inflammatory agents |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064674A1 2,4-disubstituted thiazolyl derivatives |
| 09/07/2001 | WO2001064666A1 Oxygen-containing heterocyclic compounds |
| 09/07/2001 | WO2001064655A1 2, 4-di(hetero-)arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | WO2001064653A1 Pyrimidine compounds |
| 09/07/2001 | WO2001064639A2 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 09/07/2001 | WO2001064637A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 09/07/2001 | WO2001064634A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 09/07/2001 | WO2001064633A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | WO2001064632A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 09/07/2001 | WO2001064245A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | WO2001064234A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | WO2001064225A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 09/07/2001 | WO2001064214A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064163A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof |
| 09/07/2001 | WO2001021761A3 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 09/07/2001 | WO2001019823A3 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/07/2001 | WO2001016135A3 Reverse-turn mimetics and methods relating thereto |
| 09/07/2001 | WO2001015727A3 Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof |
| 09/07/2001 | WO2001012812A3 Baff receptor (bcma), an immunoregulatory agent |
| 09/07/2001 | WO2001012804A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 09/07/2001 | WO2001010423A3 Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000076528A3 Pharmaceutical preparation containing proteins |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |